950260 - Ingenia Therapeutics Inc.(reg.s)

950260 Summary
Biopharma
Stock Price & Overview
₩15,580 -240 (-1.52%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩15,580  ≈ US$11  ·  Market cap ₩0.8tn (≈ $550m)

Half-Year Report

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 반기보고서 (2026.06)